Magenta Medical has developed a temporary venous catheter-based therapy for hospital-admitted patients with Acute Decompensated Heart Failure (ADHF). Its novel therapeutic principle is aimed at addressing a pathophysiological core element of acute heart failure – renal venous congestion and its deleterious effects on renal and cardiac function.
Company’s Keywords:
<35
<6000000
<2012